Cargando…

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”

Detalles Bibliográficos
Autores principales:	Pahalyants, Vartan, Murphy, William S., Klebanov, Nikolai, Lu, Chen, Theodosakis, Nicholas, Klevens, Monina R., Estiri, Hossein, Lilly, Evelyn, Asgari, Maryam, Semenov, Yevgeniy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2022
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961936/ https://www.ncbi.nlm.nih.gov/pubmed/35364217 http://dx.doi.org/10.1016/j.jaad.2022.03.042

Ejemplares similares

28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study
por: Pahalyants, Vartan, et al.
Publicado: (2021)

28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts
por: Murphy, William, et al.
Publicado: (2021)

27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study
por: Klebanov, Nikolai, et al.
Publicado: (2021)

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Klebanov, Nikolai, et al.
Publicado: (2021)

COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
por: Yang, Qian, et al.
Publicado: (2022)

336 Risks of COVID-19 infection and mortality for patients on biologics
por: Pahalyants, V., et al.
Publicado: (2021)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Asynchronous teledermatology in medical education: Lessons from the COVID-19 pandemic
por: Su, Mack Y., et al.
Publicado: (2020)

028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts
por: Murphy, W., et al.
Publicado: (2021)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Reply to “Comment on ‘Current outbreak of monkeypox: essentials for the dermatologist’”
por: Khanna, Urmi, et al.
Publicado: (2022)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Schultz, Brittney, et al.
Publicado: (2021)

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

COVID-19: Should sexual practices be discouraged during the pandemic?
por: Yin, ZhiQiang
Publicado: (2020)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Reply to: Comments on “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Liu, Yuangang, et al.
Publicado: (2020)

Reply to: Do interleukin 17 inhibitors increase risk of respiratory tract infections?
por: Blauvelt, Andrew, et al.
Publicado: (2020)

Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease-2019”
por: Oranges, Teresa, et al.
Publicado: (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions
por: Piccolo, Vincenzo, et al.
Publicado: (2020)

Comment on: “Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

What matters most: Why the COVID-19 pandemic should prompt us to revisit the dermatology resident selection process
por: Karasik, Daniel, et al.
Publicado: (2020)

Reply to “Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients”: Discussing specificity
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Ruggiero, Giuseppe, et al.
Publicado: (2020)

Design elements in face masks can provide an effective fit to prevent droplet spread: A reply to “Importance of nose wires in face masks”
por: Teo, Wan-Lin
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2gm560sptgk0e5nl1e4ebmpc1